These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19347573)

  • 1. Mitochondrial hexokinase and cardioprotection of the intact heart.
    Zuurbier CJ; Smeele KM; Eerbeek O
    J Bioenerg Biomembr; 2009 Apr; 41(2):181-5. PubMed ID: 19347573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic preconditioning, insulin, and morphine all cause hexokinase redistribution.
    Zuurbier CJ; Eerbeek O; Meijer AJ
    Am J Physiol Heart Circ Physiol; 2005 Jul; 289(1):H496-9. PubMed ID: 15764678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart.
    Nederlof R; Gürel-Gurevin E; Eerbeek O; Xie C; Deijs GS; Konkel M; Hu J; Weber NC; Schumacher CA; Baartscheer A; Mik EG; Hollmann MW; Akar FG; Zuurbier CJ
    J Physiol Biochem; 2016 Aug; 73(3):323-333. PubMed ID: 28258543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic preconditioning affects hexokinase activity and HKII in different subcellular compartments throughout cardiac ischemia-reperfusion.
    Gürel E; Smeele KM; Eerbeek O; Koeman A; Demirci C; Hollmann MW; Zuurbier CJ
    J Appl Physiol (1985); 2009 Jun; 106(6):1909-16. PubMed ID: 19228992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.
    Nederlof R; Eerbeek O; Hollmann MW; Southworth R; Zuurbier CJ
    Br J Pharmacol; 2014 Apr; 171(8):2067-79. PubMed ID: 24032601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of hexokinase II-mitochondrial binding blocks ischemic preconditioning and causes rapid cardiac necrosis.
    Smeele KM; Southworth R; Wu R; Xie C; Nederlof R; Warley A; Nelson JK; van Horssen P; van den Wijngaard JP; Heikkinen S; Laakso M; Koeman A; Siebes M; Eerbeek O; Akar FG; Ardehali H; Hollmann MW; Zuurbier CJ
    Circ Res; 2011 May; 108(10):1165-9. PubMed ID: 21527739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSK-3β inhibition confers cardioprotection associated with the restoration of mitochondrial function and suppression of endoplasmic reticulum stress in sevoflurane preconditioned rats following ischemia/reperfusion injury.
    Wang Y; Ge C; Chen J; Tang K; Liu J
    Perfusion; 2018 Nov; 33(8):679-686. PubMed ID: 29987974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear-encoded mitochondrial proteins and their role in cardioprotection.
    Boengler K; Heusch G; Schulz R
    Biochim Biophys Acta; 2011 Jul; 1813(7):1286-94. PubMed ID: 21255616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation to chronic continuous hypoxia potentiates Akt/HK2 anti-apoptotic pathway during brief myocardial ischemia/reperfusion insult.
    Kolar D; Gresikova M; Waskova-Arnostova P; Elsnicova B; Kohutova J; Hornikova D; Vebr P; Neckar J; Blahova T; Kasparova D; Novotny J; Kolar F; Novakova O; Zurmanova JM
    Mol Cell Biochem; 2017 Aug; 432(1-2):99-108. PubMed ID: 28290047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria and GSK-3beta in cardioprotection against ischemia/reperfusion injury.
    Miura T; Tanno M
    Cardiovasc Drugs Ther; 2010 Jun; 24(3):255-63. PubMed ID: 20490903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexokinase-mitochondrial interaction in cardiac tissue: implications for cardiac glucose uptake, the 18FDG lumped constant and cardiac protection.
    Southworth R
    J Bioenerg Biomembr; 2009 Apr; 41(2):187-93. PubMed ID: 19415474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxide-induced PKCepsilon signaling and cardioprotection.
    Wang GW; Guo Y; Vondriska TM; Zhang J; Zhang S; Tsai LL; Zong NC; Bolli R; Bhatnagar A; Prabhu SD
    J Mol Cell Cardiol; 2008 Jun; 44(6):1016-1022. PubMed ID: 18468618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury.
    Wu R; Smeele KM; Wyatt E; Ichikawa Y; Eerbeek O; Sun L; Chawla K; Hollmann MW; Nagpal V; Heikkinen S; Laakso M; Jujo K; Wasserstrom JA; Zuurbier CJ; Ardehali H
    Circ Res; 2011 Jan; 108(1):60-9. PubMed ID: 21071708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective signalling: Past, present and future.
    Jovanović A
    Eur J Pharmacol; 2018 Aug; 833():314-319. PubMed ID: 29935170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of mitochondrial HK-II elicits mitophagy and confers cardioprotection against ischemia.
    Tan VP; Smith JM; Tu M; Yu JD; Ding EY; Miyamoto S
    Cell Death Dis; 2019 Sep; 10(10):730. PubMed ID: 31570704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What can we learn about cardioprotection from the cardiac mitochondrial proteome?
    Gucek M; Murphy E
    Cardiovasc Res; 2010 Nov; 88(2):211-8. PubMed ID: 20805096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection.
    Caricati-Neto A; Errante PR; Menezes-Rodrigues FS
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo.
    Pagel PS; Krolikowski JG; Shim YH; Venkatapuram S; Kersten JR; Weihrauch D; Warltier DC; Pratt PF
    Anesth Analg; 2007 Sep; 105(3):562-9. PubMed ID: 17717207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexokinases and cardioprotection.
    Calmettes G; Ribalet B; John S; Korge P; Ping P; Weiss JN
    J Mol Cell Cardiol; 2015 Jan; 78():107-15. PubMed ID: 25264175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.